The Efficacy and Safety of F520 in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma (PTCL).
Clinical trial NCT04457830 · UNKNOWN
Trial details
- NCT number
- NCT04457830
- Sponsor
- Shandong New Time Pharmaceutical Co., LTD
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-01
- Primary completion
- 2022-07-31
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.